Draig-Therapeutics-612x460-3.png

Draig Therapeutics Limited

R&D

  • Funding stage: Series A
  • Technology type: Tech Bio
  • Cardiff
Membership category
Corporate

Sbarc Spark, 4th Floor, Maindy Road, Cardiff, CF24 4HQ, United Kingdom

Draig Therapeutics Limited at a glance

Draig is dedicated to delivering next-generation treatments for neuropsychiatric disorders through the development of highly targeted neuromodulators that redefine the existing treatment paradigm and enable people with neuropsychiatric disorders to live their best life.

About Draig Therapeutics Limited

Draig is driven by the unique expertise of our founders and a highly experienced team with a deep understanding of neuropsychiatric drug development, we are targeting fundamental, clinically validated mechanisms that underlie prevalent and debilitating neuropsychiatric disorders, such as Major Depressive Disorder (MDD).

By developing best-in-class modulators of the primary excitatory and inhibitory neurotransmitters, Glutamate and GABA, we aim to restore synaptic balance and deliver transformative therapeutic benefits for patients.

Therapeutic area(s)

Articles Draig Therapeutics Limited has contributed to